Published in PLoS Med on February 28, 2006
Visual loss in postconflict southern Sudan. PLoS Med (2006) 0.81
Genetic Polymorphisms of TLR4 and MICA are Associated with Severity of Trachoma Disease in Tanzania. Autoimmune Infect Dis (2016) 0.75
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? Lancet Infect Dis (2005) 3.67
A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis (2003) 2.36
Diagnosis and assessment of trachoma. Clin Microbiol Rev (2004) 1.96
The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect (1999) 1.87
Field trial of applicability of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma. Bull World Health Organ (2004) 1.87
How reliable is the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiol (2004) 1.62
Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull World Health Organ (2003) 1.49
Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis (2003) 1.42
Risk factors for trachoma in Mali. Int J Epidemiol (2002) 1.38
Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma? Ophthalmic Epidemiol (2002) 1.18
Antibiotics for trachoma. Cochrane Database Syst Rev (2005) 1.05
How to assess the prevalence of trachoma. Br J Ophthalmol (2005) 0.96
Trachoma grading: a new grading scheme. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique (1987) 0.94
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol (2004) 6.53
Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol (2004) 5.44
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation (2007) 4.97
The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol (2004) 4.64
Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol (2004) 3.78
Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? Lancet Infect Dis (2005) 3.67
Vision loss in Australia. Med J Aust (2005) 2.86
Microbial keratitis predisposing factors and morbidity. Ophthalmology (2005) 2.75
The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care (2003) 2.33
Trachoma. Lancet (2008) 2.11
Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology (2002) 2.05
Diabetic retinopathy management by Australian optometrists. Clin Experiment Ophthalmol (2011) 2.02
Functional presbyopia in a rural Kenyan population: the unmet presbyopic need. Clin Experiment Ophthalmol (2008) 1.87
Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci (2003) 1.79
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology (2007) 1.72
Glaucoma prevalence in Indigenous Australians. Br J Ophthalmol (2010) 1.70
A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol (2002) 1.64
The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci (2010) 1.63
Disability weights for vision disorders in Global Burden of Disease study. Lancet (2012) 1.62
Shared care for chronic eye diseases: perspectives of ophthalmologists, optometrists and patients. Med J Aust (2012) 1.60
Detection of undiagnosed glaucoma by eye health professionals. Ophthalmology (2004) 1.57
Performance of community-based glaucoma screening using Frequency Doubling Technology and Heidelberg Retinal Tomography. Ophthalmic Epidemiol (2005) 1.55
Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol (2010) 1.53
The Impact of Knowledge and Attitudes on Access to Eye-Care Services in Cambodia. Asia Pac J Ophthalmol (Phila) (2015) 1.51
Eye health in rural Australia. Clin Experiment Ophthalmol (2002) 1.51
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol (2014) 1.51
Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology (2004) 1.48
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
In vivo effects of fluoroquinolones on rabbit corneas. Clin Experiment Ophthalmol (2003) 1.46
Resources for the management of ocular emergencies in Australia. Emerg Med Australas (2011) 1.45
Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial. Clin Experiment Ophthalmol (2008) 1.41
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair. Cornea (2004) 1.38
Near-vision impairment and unresolved vision problems in Indigenous Australian adults. Clin Experiment Ophthalmol (2012) 1.37
Why optometry must work from urban and regional Aboriginal Health Services. Clin Exp Optom (2012) 1.37
The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study. Ophthalmic Epidemiol (2015) 1.36
The Impact of Vision Impairment for Children (IVI_C): validation of a vision-specific pediatric quality-of-life questionnaire using Rasch analysis. Invest Ophthalmol Vis Sci (2011) 1.30
Utilisation of eye care services by urban and rural Australians. Br J Ophthalmol (2002) 1.30
Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest Ophthalmol Vis Sci (2006) 1.27
Prevalence and associations of epiretinal membranes in the visual impairment project. Am J Ophthalmol (2005) 1.23
Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol (2010) 1.21
Uncorrected refractive errors, presbyopia and spectacle coverage: results from a rapid assessment of refractive error survey. Ophthalmic Epidemiol (2009) 1.18
Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Experiment Ophthalmol (2003) 1.15
Fungal keratitis in Melbourne. Clin Experiment Ophthalmol (2007) 1.15
Field-testing of the rapid assessment of disability questionnaire. BMC Public Health (2014) 1.14
Development of cataract and associated risk factors: the Visual Impairment Project. Arch Ophthalmol (2006) 1.13
Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clin Experiment Ophthalmol (2003) 1.12
Correlation of clinical trachoma and infection in Aboriginal communities. PLoS Negl Trop Dis (2011) 1.12
Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract (2006) 1.10
The determinants of participation in activities of daily living in people with impaired vision. Am J Ophthalmol (2004) 1.07
Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol (2005) 1.06
Strategies to control trachoma. Drugs (2009) 1.06
Economic cost of visual impairment in Japan. Arch Ophthalmol (2010) 1.05
Population-based cross-sectional study of barriers to utilisation of refraction services in South India: Rapid Assessment of Refractive Errors (RARE) Study. BMJ Open (2011) 1.05
Five-year incidence of age-related maculopathy: the Visual Impairment Project. Ophthalmology (2004) 1.05
Diabetes care in an Australian population: frequency of screening examinations for eye and foot complications of diabetes. Diabetes Care (2004) 1.03
Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment Project. Invest Ophthalmol Vis Sci (2003) 1.03
The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis. Invest Ophthalmol Vis Sci (2006) 1.02
Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990-2010. Optom Vis Sci (2016) 1.02
The effectiveness of low-vision rehabilitation on participation in daily living and quality of life. Invest Ophthalmol Vis Sci (2007) 1.02
Challenges of ophthalmic care in the developing world. JAMA Ophthalmol (2014) 1.02
Costs of interventions for visual impairment. Am J Ophthalmol (2006) 1.00
The prevalence and causes of vision loss in Indigenous Australians: the National Indigenous Eye Health Survey. Med J Aust (2010) 1.00
Barriers to accessing low vision services. Ophthalmic Physiol Opt (2003) 1.00
Utilization of eye care services by Victorians likely to benefit from eye care. Clin Experiment Ophthalmol (2004) 0.99
Can clinicians use the PHQ-9 to assess depression in people with vision loss? Optom Vis Sci (2009) 0.98
Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project. Invest Ophthalmol Vis Sci (2006) 0.98
Corneal wound dehiscence after penetrating keratoplasty. Cornea (2007) 0.97
The prevalence of trachoma in Australia: the National Indigenous Eye Health Survey. Med J Aust (2010) 0.97
Impact of cataract surgery on quality of life in patients with early age-related macular degeneration. Optom Vis Sci (2007) 0.96
Prevalence and causes of vision loss in Central and South Asia: 1990-2010. Br J Ophthalmol (2014) 0.95
Predictors of falls in the Melbourne visual impairment project. Aust N Z J Public Health (2002) 0.95
Projected prevalence of age-related cataract and cataract surgery in Australia for the years 2001 and 2021: pooled data from two population-based surveys. Clin Experiment Ophthalmol (2003) 0.95
A comparative review of measurement instruments to inform and evaluate effectiveness of disability inclusive development. Disabil Rehabil (2013) 0.95
Trachoma and poverty: unnecessary blindness further disadvantages the poorest people in the poorest countries. Clin Exp Optom (2007) 0.95
Prevalence and causes of vision loss in sub-Saharan Africa: 1990-2010. Br J Ophthalmol (2014) 0.95
Vision-related quality of life comparison for emmetropes, myopes after refractive surgery, and myopes wearing spectacles or contact lenses. J Refract Surg (2007) 0.94
Barriers to the implementation of the SAFE strategy to combat hyperendemic trachoma in Australia. Ophthalmic Epidemiol (2010) 0.93
Economic impact of primary open-angle glaucoma in Australia. Clin Experiment Ophthalmol (2011) 0.93
Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. Am J Ophthalmol (2008) 0.92
The cost of visual impairment: purposes, perspectives, and guidance. Invest Ophthalmol Vis Sci (2010) 0.92
Changes in eye care utilization following an eye health promotion campaign. Clin Experiment Ophthalmol (2007) 0.92
Observed use of sunglasses in public outdoor settings around Melbourne, Australia: 1993 to 2002. Prev Med (2006) 0.91
The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis. Invest Ophthalmol Vis Sci (2007) 0.91
The impact of diabetic retinopathy on participation in daily living. Arch Ophthalmol (2004) 0.91
Prevalence and causes of vision loss in East Asia: 1990-2010. Br J Ophthalmol (2014) 0.90
Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010. Br J Ophthalmol (2014) 0.89